This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2017 Jul 15:239:22.

doi: 10.1016/j.ijcard.2017.03.106.

Dual risk stratification for dual antiplatelet therapy: SYNTAX and CHA2DS2-VASc score

Affiliations

PMID: 28560969
DOI: 10.1016/j.ijcard.2017.03.106

Comment

Dual risk stratification for dual antiplatelet therapy: SYNTAX and CHA2DS2-VASc score

Levent Cerit. Int J Cardiol. 2017.

. 2017 Jul 15:239:22.

doi: 10.1016/j.ijcard.2017.03.106.

Author

Affiliation

¹ Department of Cardiology, Near East University, Nicosia, Cyprus. Electronic address: drcerit@hotmail.com.

PMID: 28560969
DOI: 10.1016/j.ijcard.2017.03.106

No abstract available

PubMed Disclaimer

Comment on

The optimal discontinuation of dual antiplatelet therapy in patients undergoing percutaneous coronary intervention with drug-eluting stents: A meta-analysis of randomized trials.
Wang W, Liu J, Fang J, Liu Y, An T, Zou M, Cheng G. Wang W, et al. Int J Cardiol. 2017 May 15;235:73-86. doi: 10.1016/j.ijcard.2017.02.091. Epub 2017 Feb 24. Int J Cardiol. 2017. PMID: 28284499

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Health Information